CONTENTS

 Issue 79 | February 2019

In association  with

Valsartan recall

How will the recall of API valsartan impact patients and the industry?

not so elementary

After the failure of IBM’s Watson Health, what is next for AI in healthcare?

the humble petri dish

How has this simple tool helped to shape drug discovery over the years?

treating alzheimer's

Can the link between herpes and Alzheimer’s help researchers to find a cure?

INternet identification

How is a new online tool helping scientists in the hunt for bacterial metabolites?

Clean breathing

What is the pharma industry doing to tackle respiratory issues?

Trends for 2019

What does Medidata think will be the growing trends in the world of life sciences, pharma and healthcare over the coming year?

Transforming healthcare with digital tech

The industry is undergoing dramatic change as new tech brings disruption

02/24/2024 11:38:16
  • Home | Deep Breath
  • In this issue
  • Scandinavian Health Ltd Company Insight
  • Scandinavian Health Ltd.
  • Contents
  • Daiichi Jitsugyo
  • Hapa Company Insight
  • News
  • International Cannabis and Cannabinoid Institute (ICCI) Company Insight
  • International Cannabis and Cannabinoid Institute (ICCI)
  • The pharma industry briefing
  • Molnar Company Insight
  • Molnar
  • A costly oversight: the ongoing impact of the valsartan recall
  • Medelpharm
  • Not so elementary, Watson: the roadblocks for AI in pharma
  • Zenatek
  • The Petri dish: telling the story of pharma’s most humble ally
  • AtoZ-CRO GmbH Company Insight
  • AtoZ-CRO GmbH
  • Exploring the causal link between herpes and Alzheimer’s
  • Pfeiffer Vacuum
  • antiSMASH: on the hunt for new antibiotics
  • Pfanstiehl
  • Tackling consequences of air pollution with drug R&D
  • Sanofi
  • Trends for 2019: from global studies to digital therapeutics
  • Events
  • Next issue
01/31/2019 00:00:00